One is retatrutide, an injectable drug Eli Lilly is developing thats a triple agonist, meaning that in addition to GLP-1 and GIP, it also targets glucagon
Proces w 3 krokach: Wypeniasz formularz medyczny podajesz wyniki HbA1c, BMI, leki, choroby wspistniejce Lekarz przeprowadza wideokonsultacj ocenia wskazania, przeciwwskazania, omawia dawkowanie Otrzymujesz e-recept kod SMS trafia w 15 minut, realizujesz w kadej aptece w Polsce lub UE Chcesz zacz
While real-life experience can vary, heres what clinical trial results have found: Orforglipron : Phase 3 obesity trials in people without diabetes show up to 11% weight loss after 72 weeks when taking the highest dosage studied
Notably, 45.3% of the high-dose group achieved over 30% weight loss, paralleling results often achieved by bariatric surgery